The relative importance of catalytic vs. structural functionalities of IRAK1 is an important consideration for the development of IRAK1 inhibitors for clinical use, particularly in radioresistant cancer, and will be discussed in detail in the closing sections of this review. The gene discussed is IRAK1; the disease is cancer.